Please add "communications@pancan.org" to your Email Address Book. Learn how.

Register now for Pancreatic Cancer Advocacy Day, June 25 - 26, Washington, DC

» Learn more.
A Washington, DC, Educational Event
Learn the latest about pancreatic cancer in person from leading specialists in the field.
Register today.
One-on-One Support and Information
Contact a dedicated PALS Associate today for personalized pancreatic cancer information.
Your Local Affiliate Facebook Page
Receive up-to-the-minute news on the local effort and connect with volunteers in your community. Find your local Facebook page.
Research
Learn about recent progress made in understanding disease progression, risk factors and other aspects of pancreatic cancer.
Awareness, Hope
and Heart

It's time to remember your sweetheart. Find watches and other purple awareness items for Valentine's Day at Shop Purple.
Attend Advocacy Day this June
Registration for the sixth annual Pancreatic Cancer Advocacy Day in Washington, DC, is now open. Find out more.
Keep the Memory Alive
Create a tribute page for your loved one and help others in need.
Thank You Again, Tempur-Pedic®
Our leading Corporate Champion concluded its third year of generous support by topping $1 million in donations for the cause.
Harness the Power
of Matching

Matching gifts programs can substantially increase your donation's value. See how to supercharge your contribution.
Making Giving Easy
Simplify your philanthropy. Set up a recurring donation charged to your credit card each month.

A Message from the President and CEO

The guest columnist this month is our new Vice President of Scientific and Medical Affairs, Lynn Matrisian, PhD. With an extensive academic background in cancer research, Lynn has developed important relationships with scientists, clinicians and organizations that influence the pancreatic cancer community including the American Association for Cancer Research and the National Cancer Institute. We are delighted she has joined our team.

Julie Fleshman, JD, MBA
President and CEO
Pancreatic Cancer Action Network




Dear Pancreatic Cancer Action Network Friends:

By several measures, January's inaugural National Pancreatic Cancer Clinical Trial Awareness Month was a great success. Our Patient and Liaison Services team received more than 600 calls seeking information about pancreatic cancer clinical trials searches, and the efforts of our staff and volunteers led to heightened awareness among the public about the importance of clinical trials, especially in the fight against pancreatic cancer.

While enrolling more patients in clinical trials will determine whether drugs under current investigation carry promise in the treatment of pancreatic cancer, we are also aware that new drugs and treatment strategies will be needed as we move forward. Research projects taking place in laboratories across the country offer the potential of enhancing our understanding of the biology of pancreatic cancer at all stages of the disease.

This knowledge will aid in the design and development of new clinical trials to treat pancreatic cancer, as well as uncovering new approaches to detecting, diagnosing, and potentially preventing it. We need to work together to make sure the right patients are treated with the right drugs at the right stage of their disease process.

The growing momentum in the pancreatic cancer research community is palpable. In January alone, three Pancreatic Cancer Action Network grant recipients published exciting findings about their investigations in major scientific journals. (Please click here for more information.) Their research and that of their fellow scientists enhances our understanding of the genetic signals necessary for the growth and maintenance of pancreatic tumors. The findings also help us learn more about the steps involved in the spread of the disease to other organs.

Such progress in the field is proof that the Pancreatic Cancer Action Network's strategy of building and sustaining a robust, comprehensive research community is succeeding. Collaborations are forming between scientists at various institutions, the American Association for Cancer Research is hosting its first special conference devoted to pancreatic cancer this year, and we are improving our understanding of all aspects of pancreatic cancer biology.

As we wage the war against pancreatic cancer, we need to assemble a strong army, equip them with the most powerful tools and resources available, and gather all the information necessary to discover the vulnerabilities of our enemy. With this approach, we can design and implement clinical trials and add new and better treatments to our arsenal.

I am honored to have joined the Pancreatic Cancer Action Network at this exciting time in its history, and am eager to be a part of this community as we move towards our goal of doubling the survival rate of pancreatic cancer by 2020.

All the best,


Lynn Matrisian, PhD
Vice President, Scientific and Medical Affairs
Pancreatic Cancer Action Network

 

For information about including the Pancreatic Cancer Action Network in your estate planning,
click here.



 

Privacy Policy       Unsubscribe